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ABSTRACT
Serum is the body fluidmost often used in biomarker discovery. Albumin, themost abundant serum protein, contributes approximately 50% of the
serum protein content, with an additional dozen abundant proteins dominating the rest of the serum proteome. To profile this challenging protein
mixture by proteomics, the abundant proteinsmust be depleted to allow for detection of the low-abundant proteins, the primary biomarker targets.
Current serum depletion approaches for proteomics are costly and relatively complex to couple with protein digestion. We demonstrate a simple,
affordable serum depletion methodology that, within a few minutes of processing, results in two captured serum fractions – albumin-depleted
and albumin-rich – which are digested in situ. We believe our method is a useful addition to the biomarker sample preparation toolbox.
METHOD SUMMARY
We describe a method for simple albumin depletion by serum fractionation coupled with proteomics analysis. The method is based on selective
protein adsorption to quartz under basic conditions. While many serum proteins are captured and can subsequently be eluted, albumin and some
other proteins are not retained and pass through the quartz trap. The flow-through albumin-rich fraction is diluted with methanolic ammonium
acetate solution and captured in a second quartz trap. Both fractions are digested in situ for proteomics analysis.
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In translational medical research, serum is a valuable source of protein biomarker molecules. However, common abundant serum pro-
teins interfere with identification of the low-level proteins of interest by proteomics and need to be depleted from the serum samples to
increase the protein identification efficiency. Albumin is the most abundant serum protein, constituting approximately 50% of the total
serum proteome [1]. Current serum depletion methods, such as those based on affinity removal, are expensive and relatively complex
in the downstream hyphenation with proteomics processing [2]. Recently we described two bottom-up proteomics sample preparation
methods, STrap (Suspension Trapping) and SiTrap (Simultaneous Trapping), based on protein capture and digestion in situ in quartz and
cellulose depth filter traps [3,4]. While working with serum samples, we noticed that at basic pH (e.g., diluted in 20mM triethylammonium
bicarbonate [TEAB] buffer), serum albumin is not trapped by quartz depth filters but many other serum proteins are captured (Figure 1A).
One of the possible explanations for the behavior of albumin is that its isoelectric point is 4.7. At basic pH, albumin is negatively charged;
as the silica surface is also negatively charged at this pH, albumin would not be retained by the quartz filter due to electrostatic repulsion.
The simple serum fractionation results in two protein fractions. The captured fraction, depleted of albumin, is directly digested in the
trapping unit, while the flow-through ‘albumin-rich’ fraction is diluted with six volumes of 30 mM ammonium acetate in methanol and
subsequently captured and digested in another trapping unit (Figure 1B).
To evaluate this approach further, 0.5 μl of normal human serum was either digested directly by the STrap technology (six replicate
samples in total) or diluted with 20 mM TEAB buffer and processed by fractionation as described above using trapping quartz tips,
resulting in two fractions, the captured and the flow-through (three replicates for each fraction, six samples in total). The results of mass
spectrometry analysis using each approach were then merged. The fractionation approach led to an increase of approximately 32%
in protein identifications compared with the direct approach (242 vs 183 proteins, respectively) (Figure 2A & B). In addition, combined
digests of the three ‘depleted’ fractions were compared with the combined three ‘direct’ digests. An increase in protein identifications
of 28% was observed for the ‘depleted’ fractions (218 vs 170 proteins, respectively), proving that most identifications come from the
‘depleted’ fraction. It is worth noting that the simple strategy used for capture and digestion of the flow-through serum albumin fraction
– sample dilution in six volumes of methanolic ammonium acetate, protein trapping, reduction/alkylation and digest – could also be
utilized for processing of less complex protein mixtures such as antibody preparations. Even though simple in execution, the proposed
method is a useful, practical and rapid sample preparation tool for a proteomic biomarker laboratory.
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Figure 1. In-tip serum fractionation based on selective protein adsorption on quartz. (A) The simple serum fractionation approach using quartz tips
produces two fractions, one of which is devoid of albumin. The loaded serum, captured and flow-through fractions were run on NuPAGE 4–12% Bis-Tris
protein gel and stained with InstantBlue Coomassie stain. (B) Schematics of the proposed serum fractionation and digestion methodology. A serum
sample is diluted with TEAB buffer and loaded into a quartz trapping tip. The bound proteins are reduced and alkylated in situ. After washing, digestion
is performed by introducing a trypsin solution into the tip. The uncaptured flow-through fraction, in turn, is diluted with methanolic solution of
ammonium acetate and loaded into another quartz tip, where the proteins are also trapped, reduced/alkylated, and digested in situ.
MW: Molecular weight; TEAB: Triethylammonium bicarbonate.
Trapping units
Trapping tips were constructed by inserting quartz depth filter plugs into 200-μl pipette tips as described previously [3,5]. For the sample
processing steps involving centrifugation (load, wash and elution), the tips were placed in 2.0- or 1.5-ml sample tubes with the aid of
tube adapters [3].
Serum processing
A sample of normal human serum was obtained from the Leeds Multidisciplinary Research Tissue Bank. 0.5 μl of the serum was either
processed directly by the OQ STrap (Only Quartz Suspension Trapping) protocol [5] in the trapping tips using serum solubilization with
25 μl 5% SDS in 50 mM Tris-HCl, pH 7.6 and in situ tryptic digestion (six replicate samples in total), or was processed utilizing the
proposed method, in other words, diluted with 30 μl of 20 mM TEAB buffer and processed by fractionation in the trapping tips, resulting
in two fractions, ‘captured’ (albumin-depleted) and ‘flow-through’ (albumin-rich) (three replicates for each fraction, six samples in total).
For the proposed methodology, the serum diluted in TEAB buffer was loaded into the trapping tip and gently pushed through with the
aid of a syringe with a tip adapter; the ‘flow-through’ fraction was collected. The tip with the ‘captured’ fraction was then inserted into a
2.0-ml sample tube and washed consecutively with 100 and 40μl of 20mM TEAB using centrifugation at 2500 ×g. Reduction/alkylation
and digestion of the trapped proteins were performed in situ as previously described for the SiTrap processing [4]. The ‘flow-through’
fraction was diluted with six volumes of 30 mM ammonium acetate in methanol (prepared by mixing 1 M ammonium acetate solution
with anhydrous methanol) before being trapped and digested in another trapping tip in the same way as the ‘captured’ fraction.
Proteomics analysis
The resulting peptides were separated online by reversed-phase capillary liquid chromatography using an EASY-nLC 1000 system (Prox-
eon) connected to a custom-made 30-cm capillary emitter column (inner diameter 75μm, packed with 3-μmReprosil-Pur 120 C18 media,
DrMaisch). The EASY-nLC 1000 systemwas coupledwith a linear ion trap– orbitrap (LTQ-Orbitrap™) Velosmass spectrometer (Thermo).
The acquisition time was 90 min and the main part of the gradient was 3–22% acetonitrile in 0.1% formic acid. Survey mass spectrom-
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Figure 2. Serum protein identification by the fractionation and direct approaches. The fractionation approach leads to an increase of ∼32% in protein
identifications. (A) Histogram showing comparison of fractionation serum processing with the direct serum digest method. Totals represent proteins
identified with at least two peptides. (B) Venn diagram showing proteins identified using the fractionation serum processing versus the direct serum
digest method (proteins identified with at least two peptides).
etry scans (scan range of 305–1350 amu) were acquired in the Orbitrap with a resolution of 60,000. The most intense ions (up to 20
per scan) were fragmented and analyzed in the ion trap. Data were processed against a Uniprot human database (October 2018) with
the MaxQuant 1.5.2.8 software package [6,7]. Carbamidomethylation of cysteine was set as a fixed modification, with protein N-terminal
acetylation and oxidation of methionine as variable modifications. The maximum protein and peptide false discovery rates were set to
0.01. Only proteins identified with at least two peptides were considered.
Future perspective
In this work we present a simple, streamlined concept for fractionation-capture and in situ digestion of serum proteins for bottom-up
proteomics analysis. We believe our methodology could be of practical utility to scientists engaged in clinical proteomics research and
serum or plasma biomarker profiling. To remove the bottleneck of having to make the protein trapping units in-house to ascertain their
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reproducible performance, the units, in different formats and capacities, will be made commercially available. Such availability is key for
the wide acceptance of the method.
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